Now, keep up to date
with daily feeds of newly posted stories
about America's Seniors...click on the box
to the left
Post Heart Attack, Patients with Lower
Kidney Function not taking Prescribed Meds
Newswise, January 14, 2011 — Among older adults with a
recent heart attack (myocardial infarction),
those with lower levels of kidney function
are less likely to take their medications as
prescribed, according to a study appearing
in an upcoming issue of the Clinical
Journal of the American Society of
Nephrology (CJASN).
"Several types of medications have proven benefit for
preventing recurrent heart attacks, yet only
about half of people with heart disease take
their medications correctly," comments
Wolfgang C. Winkelmayer, MD, ScD (Stanford
University School of Medicine, Palo Alto,
CA). "Adherence was lower in patients with
more pronounced kidney dysfunction."
The researchers studied 2,103 patients aged 65 or older
with a recent heart attack. Pharmacy
insurance claims records were used to
determine the percentage of days that
patients actually had their prescribed
medications.
The results showed low long-term adherence rates for three
major classes of heart medications:
angiotensin-converting enzyme inhibitors/angiotensin-receptor
blockers (ACEIs/ARBs), beta-blockers, and
statin drugs.
Over three years' follow-up, the patients had their
prescribed drugs for only 50 to 60 percent
of the time.
For ACEIs/ARBs and beta-blockers, medication adherence was
significantly lower for patients who had
lower levels of kidney function at the
beginning of the study. Adherence to statin
drugs was not significantly related to
kidney function.
"Since poor medication adherence increases the risk of
hospitalization and death, it is important
to understand the scope of the problem,"
Winkelmayer explains. In a previous study in
the same group of patients, the researchers
found low medication adherence rates within
the first 90 days after heart attack.
"In the current study, we wanted to extend these findings
to examine long-term outpatient medication
adherence, particularly in patients with
kidney dysfunction, who are at high risk for
recurrent heart attacks but who have not
been studied extensively to date." "
Future strategies to improve medication adherence and
clinical outcomes will need to pay special
attention to this high-risk population."
The study had some important limitations. Kidney function
was measured based on a single lab test
performed in the hospital, which may
underestimate the true baseline kidney
function.
The study included a sample of elderly, low-income patients
with a high proportion of whites and women,
so the results may not be applicable to a
more diverse population.
Also, since medication adherence was measured using
insurance claims data, the researchers were
unable to determine why patients weren't
following their prescriptions.
"For example, the medication may have been purposely
discontinued by the treating physician due
to unwanted side effects," says Winkelmayer.